Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Conditions
Lymphoma
Interventions
DRUG

bexarotene

DRUG

methoxsalen

PROCEDURE

UV light therapy

Trial Locations (19)

10019

St. Luke's-Roosevelt Hospital Center - Roosevelt Division, New York

11733

StonyBrook Dermatology Associates, P.C., East Setauket

37920

Knoxville Dermatology Group, P.C., Knoxville

48202

Henry Ford Hospital, Detroit

60611

Northwestern University Medical Center, Chicago

60612

Rush-Presbyterian-St. Luke's Medical Center, Chicago

70112

Tulane University School of Medicine, New Orleans

72205

University of Arkansas for Medical Sciences, Little Rock

75703

Tyler

94305

Stanford University Medical Center, Stanford

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

80010-0510

University of Colorado Health Science Center, Aurora

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

70459-0059

Slidell

02118-2393

Boston Medical Center, Boston

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

44106-5065

Ireland Cancer Center, Cleveland

75235-9154

Simmons Cancer Center - Dallas, Dallas

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Millennix

INDUSTRY